International legal practice Osborne Clarke has advised Intelligent Ultrasound Group plc, the artificial intelligence (AI) based ultrasound software and simulation company, on its first long-term licence and co-development agreement for its AI software with one of the world’s leading ultrasound equipment manufacturers.
The Group’s range of AI-based software aims to boost scanning quality and to streamline sonographer workflow in medical ultrasound specialties, such as anaesthesiology, obstetrics, gynaecology, radiology and primary care medicine.
The long-term agreement will enable the integration of Intelligent Ultrasound’s real-time image analysis software onto a range of specialty specific ultrasound systems marketed in the global healthcare market. Co-development work with the OEM partner will commence immediately, with initial royalty per unit revenues expected during 2021 following regulatory approval. Terms of the agreement are confidential and undisclosed for commercial reasons.
Partner Dr Janita Good and Senior Associate Jane Whitcombe advised Intelligent Ultrasound.
Osborne Clarke’s life science and healthcare sector team has a strong track record of providing highly sophisticated advice to biotech clients on cutting-edge issues, across multiple service lines. They work with the biggest pharma and medical devices companies in the market.
